Abstract

The American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) is an international data-sharing consortium focused on enabling advances in precision oncology through the gathering and sharing of tumor genetic sequencing data linked with clinical data. The project’s history, operational structure, lessons learned, and institutional perspectives on participation in the data-sharing consortium are reviewed. Individuals involved with the inception and execution of AACR Project GENIE from each member institution described their experiences and lessons learned. The consortium was conceived in January 2014 and publicly released its first data set in January 2017, which consisted of 18,804 samples from 18,324 patients contributed by the eight founding institutions. Commitment and contributions from many individuals at AACR and the member institutions were crucial to the consortium’s success. These individuals filled leadership, project management, informatics, data curation, contracts, ethics, and security roles. Many lessons were learned during the first 3 years of the consortium, including on how to gather, harmonize, and share data; how to make decisions and foster collaboration; and how to set the stage for continued participation and expansion of the consortium. We hope that the lessons shared here will assist new GENIE members as well as others who embark on the journey of forming a genomic data–sharing consortium.

Highlights

  • The American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) is an international genomic data–sharing consortium focused on enabling advances in the understanding and treatment of cancer

  • We hope that the lessons shared here will assist new GENIE members and others who embark on the journey of forming a genomic data–sharing consortium

  • Each institution that joined GENIE underwent an internal cost-benefit analysis, legal and administrative tasks related to joining the consortium, ascopubs.org/journal/cci JCOTM Clinical Cancer Informatics 7 and work to pull and process data submitted to GENIE

Read more

Summary

INTRODUCTION

The American Association for Cancer Research (AACR) Project Genomics Evidence Neoplasia Information Exchange (GENIE) is an international genomic data–sharing consortium focused on enabling advances in the understanding and treatment of cancer. The consortium is deeply committed to open science and data sharing as long as patient privacy is protected To this end, terms of access have been implemented that require steering committee approval of any data redistribution, which is predicated on the ability of the receiving platform to implement the same terms of access that GENIE has implemented. Each institution that joined GENIE underwent an internal cost-benefit analysis, legal and administrative tasks related to joining the consortium, ascopubs.org/journal/cci JCOTM Clinical Cancer Informatics 7 and work to pull and process data submitted to GENIE. Institutions were pleasantly surprised at how willing all were to work together and share data

DISCUSSION
The AACR Project GENIE Consortium
10. Synapse
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call